Account
Inquiry
Tirzepatide pens contain a dual GIP and GLP-1 receptor agonist that has shown significant potential in metabolic research applications. Our pharmaceutical-grade tirzepatide is supplied in sterile vials with 99.7% purity, making it ideal for controlled laboratory studies.
The compound (LY3298176) works by activating both the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, which may influence glucose metabolism and weight management pathways. Each batch undergoes rigorous quality control testing to ensure research consistency.
For research institutions requiring larger quantities, we offer bulk tirzepatide pens with customizable packaging solutions. Our manufacturing facility maintains strict compliance with quality standards throughout production.
Note: This product is for research use only. Not for human consumption. Proper laboratory handling procedures should always be followed when working with tirzepatide pens or any research compounds.
